Canada Opens Access for Psilocybin and MDMA Therapy
Cannabis Law Report
FEBRUARY 24, 2022
Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions.
Let's personalize your content